Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.89% | -5.24% | -0.12% | 7.04% | 6.04% |
| Total Depreciation and Amortization | -10.23% | -24.54% | -37.83% | -38.58% | -31.89% |
| Total Amortization of Deferred Charges | 7.15% | 7.15% | 7.15% | 14.36% | 14.36% |
| Total Other Non-Cash Items | -58.59% | -99.15% | -82.18% | -66.28% | 122.77% |
| Change in Net Operating Assets | 89.01% | 54.89% | -221.31% | -986.82% | -316.79% |
| Cash from Operations | 212.24% | 35.77% | -27.95% | -77.60% | -82.52% |
| Capital Expenditure | 10.43% | 7.93% | 3.09% | 0.63% | 0.56% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -254.24% | -256.77% | -209.86% | 30.70% | 39.38% |
| Divestitures | -109.02% | -- | -- | -- | -- |
| Other Investing Activities | 172.74% | 172.85% | 119.64% | -86.40% | -58.96% |
| Cash from Investing | 45.85% | 41.38% | 7.27% | -7.15% | -0.62% |
| Total Debt Issued | 90.86% | 360.60% | 174.12% | -24.49% | -18.68% |
| Total Debt Repaid | -1,749.72% | -656.81% | -10.97% | 86.19% | 95.35% |
| Issuance of Common Stock | -61.84% | -28.64% | 45.39% | 72.54% | 55.10% |
| Repurchase of Common Stock | -25.34% | -22.97% | -8.43% | 12.16% | -0.71% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.89% | -6.47% | -8.10% | -9.38% | -10.59% |
| Other Financing Activities | -270.00% | -277.78% | -71.43% | -63.33% | -72.22% |
| Cash from Financing | -150.58% | 73.15% | 135.62% | 81.05% | 80.20% |
| Foreign Exchange rate Adjustments | 112.50% | -150.00% | -500.00% | -- | -300.00% |
| Miscellaneous Cash Flow Adjustments | -114.29% | -- | -- | -- | -- |
| Net Change in Cash | 159.04% | 132.53% | 304.65% | -249.15% | -198.84% |